Angelika Vollmar
Hat mitgewirkt an:
-
Role of the transcriptional coactivators Megakaryoblastic Leukemia Proteins 1 and 2 in tumorigenesis
-
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
-
Über immunstimulierende Wirkprinzipien aus Eupatorium perfoliatum (L.) und Eupatorium cannabinum (L.)
-
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy